Both in Pharmaceuticals
Alnylam Pharmaceuticals vs Jazz Pharmaceuticals
Over the past year ALNY returned −63.2% and JAZZ returned +66.0%; their daily moves had a correlation of 0.09.
ALNY −63.2% JAZZ +66.0%Growth of $1, one year, split-adjusted
| Metric | ALNY | JAZZ |
|---|---|---|
| Price | $159.89 | $229.74 |
| Market cap | $21.42B | $14.91B |
| Today | +1.20% | +7.13% |
| 1 month | −27.3% | −2.7% |
| 6 months | −46.9% | +8.2% |
| Year to date | −59.8% | +35.1% |
| 1 year | −64.9% | +66.9% |
| Revenue growth (YoY) | +16.7% | +10.4% |
| Gross margin | 75.2% | 91.1% |
| Net margin | 148.6% | −38.9% |
| P/E (TTM) | 7.9× | 72.4× |
| Price / sales | 4.3× | 3.2× |
| Net cash | $2.57B | -$2.71B |
| Dividend yield | — | — |
| Volatility (60d) | 72.9% | 31.5% |
| Short % of float | 4.9% | 9.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).